6 min read
2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress
2021 – A true testimony that we sit at the intersection of significant new opportunities The significant opportunities at the intersection of
Tag : Enlightenbio Blog
6 min read
3 min read
Patient-Centric Rare Disease Genome Maps Join The Web
For far too long, rare disease patients and their guardians have had to wait “forever” for genetic information to be returned back to them. All
Singular Genomics Launches the G4 Sequencing Platform
Next-generation sequencing platform will provide up to three times more data output per hour than other benchtop instruments, while offering
Rebus Bio Continues Expansion of Industry-leading Spatial Omics Platform with Breakthrough High-Plex Technology
EEL assay overcomes well-known limitations in spatial biology SANTA CLARA, Calif. & STOCKHOLM–(BUSINESS WIRE)–Rebus Biosystems Inc, (“Rebus
PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases
Collaboration aims to identify variants not easily detectible by short-read sequencing, increasing diagnostic yield in rare disease patients MENLO
1 min read
Bionano Genomics Acquiring BioDiscovery – The Perfect Alignment of the Stars
One of October’s headlines in the field of genomics and genetics included the acquisition of BioDiscovery by Bionano Genomics. I spoke with
Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease
The iHope Genetic Health program will expand access to whole-genome sequencing to low- and middle-income communities around the world, with more than
Color announces Series E financing, at a valuation of $4.6 billion, to accelerate expansion of accessible and equitable public health infrastructure
With an additional $100 million in funding, Color will use the infrastructure built during the pandemic to increase access to essential healthcare
1 min read
Enabling Precision Medicine: Life (Sciences) in 2030
Just 20 years ago, some expected the human genome to hold all the answers. Instead, we accumulated an almost unlimited backlog of new questions – a
Scientific Integrity: A Coincidental Encounter
I recently interviewed the Dutch scientist, Dr. Elisabeth Bik, a microbiome and science integrity consultant. After years of working as a research
Mayo Clinic collaborates with Personalis Inc. to expand cancer genomic testing
ROCHESTER, Minn., and MENLO PARK, Calif. — Mayo Clinic announced an agreement on Tuesday, Oct. 12 that will allow it to offer clinical-grade
Bionano Genomics to Acquire BioDiscovery, Furthering Bionano’s Vision of Creating the Most Comprehensive Variant Analysis Platform in Genomics
Designed to accelerate the adoption of optical genome mapping (OGM) with the integration of BioDiscovery’s N x Clinical software solution for
Genoox and Aspira Women’s Health Inc. Partner to Develop and Deliver Data-Driven Insights to Advance Women’s Health
This partnership will expand on the information currently available to establish and improve advanced testing to accurately diagnose complex diseases
1 min read
OncoDNA teams up with SOPHiA GENETICS to enable laboratories to establish data-driven medicine as a standard of care
Sept. 30, 2021 For the use with SOPHiA DDM to match tumor genomic profiles with targeted therapies OncoDNA, a genomic and theranostic company
Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence
Monday, September 20, 2021 Omniome’s high accuracy short-read sequencing platform expected to significantly expand PacBio’s market